Discontinuation report MYLAN-GLICLAZIDE
Report ID | 16126 |
Drug Identification Number | 02229519 |
Brand name | MYLAN-GLICLAZIDE |
Common or Proper name | GLICLAZIDE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT, 60BL |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-12-01 |
Actual discontinuation date | 2017-12-01 |
Remaining supply date | 2017-12-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-07-18 | English | Compare |
v2 | 2017-07-18 | French | Compare |
v3 | 2017-10-23 | English | Compare |
v4 | 2017-10-23 | French | Compare |
v5 | 2017-12-01 | English | Compare |
v6 | 2017-12-01 | French | Compare |
v7 | 2017-12-02 | English | Compare |
Showing 1 to 7 of 7